EUVIMEDEUVIMED entdecken
Crossref

Simultaneous inhibition of mTOR and STING as an approach to reduce alpha-synuclein and lysosphingolipid levels in peripheral blood monocytederived macrophages and the SH-SY5Y cell line: implications for therapy of Parkinson’s disease

A I Bezrukova, K S Basharova, E S Galkina, O S Epifanivskaya, G V Baydakova, E Yu Zakharova, S N Pchelina, T S Usenko

Biomeditsinskaya Khimiya · 2026-03 · 72 (1) · 42-61

DOI: 10.18097/pbmcr1616 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomeditsinskaya Khimiya, 2026. Verfasst von A I Bezrukova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Petersburg Nuclear Physics Institute named by B.P. Konstantinov of NRC "Kurchatov Institute", Gatchina, Leningrad region, Russia; First Pavlov State …. Hauptthemen laut MEDLINE: alpha-Synuclein, TOR Serine-Threonine Kinases, Membrane Proteins, Parkinson Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 88 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The combined effects of two inhibitors, Torin 1, acting on mTOR, a key regulator of autophagy, and H-151, inhibiting STING, a key regulator of inflammation, on the autophagolysosomal system, have been studied in a primary culture of peripheral blood macrophages from healthy donors and the SH-SY5Y neuroblastoma cell line. Combined use of these drugs resulted in a decrease in the levels of lysosphingolipids, triggering alpha-synuclein oligomerization, as well as a decrease in the levels of monomeric and neurotoxic phosphorylated (Ser129) alpha-synuclein and an increase in tyrosine hydroxylase. These results open new prospects for the use of combination therapy with these proposed drugs in the treatment of both diseases associated with lysosomal dysfunction and neurodegenerative pathologies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinTOR Serine-Threonine KinasesMembrane ProteinsParkinson DiseaseMacrophagesHumansCell Line, TumorAutophagyPhosphorylationTyrosine 3-MonooxygenaseNaphthyridines

Stichwörter der Autor:innen

STINGalpha-synucleinautophagylysosomal hydrolase activitymTOR

Substanzen

alpha-SynucleinTOR Serine-Threonine KinasesMembrane ProteinsMTOR protein, human1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo(h)(1,6)naphthyridin-2(1H)-oneTyrosine 3-MonooxygenaseNaphthyridines

Autor:innen und Institutionen

  • Petersburg Nuclear Physics Institute named by B.P. Konstantinov of NRC "Kurchatov Institute", Gatchina, Leningrad region, Russia; First Pavlov State Medical University of St. Petersburg, Saint Petersburg, Russia.
  • Petersburg Nuclear Physics Institute named by B.P. Konstantinov of NRC "Kurchatov Institute", Gatchina, Leningrad region, Russia.
  • Raisa Gorbacheva Memorial Research Institute for Pediatric Oncology, Hematology and Transplantation, Saint Petersburg, Russia.
  • Medical Genetic Research Center, Moscow, Russia.

Zitieren

APA

Bezrukova, A. I., Basharova, K. S., Galkina, E. S., Epifanivskaya, O. S., Baydakova, G. V., Zakharova, E. Y., Pchelina, S. N., & Usenko, T. S. (2026). Simultaneous inhibition of mTOR and STING as an approach to reduce alpha-synuclein and lysosphingolipid levels in peripheral blood monocytederived macrophages and the SH-SY5Y cell line: implications for therapy of Parkinson’s disease. Biomeditsinskaya Khimiya, 72(1), 42-61. https://doi.org/10.18097/pbmcr1616

Vancouver

Bezrukova AI, Basharova KS, Galkina ES, Epifanivskaya OS, Baydakova GV, Zakharova EY, et al. Simultaneous inhibition of mTOR and STING as an approach to reduce alpha-synuclein and lysosphingolipid levels in peripheral blood monocytederived macrophages and the SH-SY5Y cell line: implications for therapy of Parkinson’s disease. Biomeditsinskaya Khimiya. 2026;72(1):42-61. doi:10.18097/pbmcr1616

BibTeX
@article{Bezrukova2026,
  author = {Bezrukova, A I and Basharova, K S and Galkina, E S and Epifanivskaya, O S and Baydakova, G V and Zakharova, E Yu and Pchelina, S N and Usenko, T S},
  title = {Simultaneous inhibition of mTOR and STING as an approach to reduce alpha-synuclein and lysosphingolipid levels in peripheral blood monocytederived macrophages and the SH-SY5Y cell line: implications for therapy of Parkinson’s disease},
  journal = {Biomeditsinskaya Khimiya},
  year = {2026},
  volume = {72},
  number = {1},
  pages = {42--61},
  doi = {10.18097/pbmcr1616}
}
Kostenlos starten →